Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent [5]

Irish Medical Journal

Volumn 98, Issue 4, 2005, Pages 118-

  Tobin, A M ^a   Barragry, J ^a   Kirby, Brian ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BLEACHING AGENT; CLOBETASOL PROPIONATE; DEXAMETHASONE; HYDROCORTISONE; MOVATE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; LETTER; LICENCE; ORTHOSTATIC HYPOTENSION; STRIA; THYROID FUNCTION TEST; TINEA FACIEI;

ADMINISTRATION, TOPICAL; ADRENAL GLANDS; ADULT; CLOBETASOL; DRUG AND NARCOTIC CONTROL; FEMALE; GLUCOCORTICOIDS; HUMANS; SKIN PIGMENTATION;

EID: 19644386729     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Keane FM, Munn SE, Taylor NF, du Vivier AW. Unregulated use of clobetasol propionate. Br J Derm 2001; 144, 1086-1099.
2. Ohman EM, Rogers S, Meenan FD et al., Adrenal suppression following low-dose topical clobetasol propionate. J R Soc Med 1988; 144: 1086-1099.
3. Gilbertson ED, Spellman MC, Piacquaido DJ et al., Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations. J Am Acad Dermatol 1998; 38:318-21.
4. Cornell RC, Stoughton RB. Use of glucocorticoids in psoriasis. Pharmacol Ther 1980; 11: 497-508.
5. Barnetson RSC, White AD. The use of corticosteroids in dermatological practice. Med J Aust 1992; 156: 428-31.
6. Lawlor F. Ramabala K. latrogenic Cushing's syndrome: A cautionary tale. Clin Exp Dermatol 1984; 9: 286-9.
7. Lauerma AL, Reitamo S. Contact allergy to corticosteroids. J Am Dermatol. 1993; 28: 618-22.
8. Nathan AW, Rose GL. Fatal iatrogenic Cushing's Syndrome. Lancet. 1979; 1: 207.
9. Sneddon MIB. Les effets nocifs des steroids en application locale. Journey Francor-Britannic de Dermatology 1970; 77: 670-2.